1. Refractory immune TTP following Pfizer‐BioNTech COVID‐19 vaccine successfully salvaged with caplacizumab. (18th May 2022) Authors: Laverdure, Eva; Sperlich, Catherine; Fox, Susan Journal: Journal of thrombosis and haemostasis Issue: Volume 20:Number 7(2022) Page Start: 1696 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗